“Sometimes the impossible only comes later”
Established in 2020, Gate2Brain is a spinoff that is based on a novel technology to transport drugs to the brain. The company, born from the Sant Joan de Déu Hospital, the University of Barcelona and the Barcelona Biomedical Research Institute (IRB Barcelona), has developed a new product to transport the corresponding drugs to in the brain and thus be able to fight different brain diseases.
Meritxell Teixidó, CEO of Gate2Brain shares in this interview the reason why she decided to start, what she has learned during these two years with the company and the next steps of the startup. As a curiosity, the entrepreneur was recently awarded the #WomenStartupAwards prize in the Inspiration category.
PhD in Peptide Science and Genetic Algorithms from the University of Barcelona, where she also graduated in Chemistry and where she did a Master’s in Organic Chemistry and Peptide Science. In July 2020, she created Gate2Brain after working as a research associate scientist at IRB Barcelona for more than 14 years.